Hyperlipidemia
Conditions
Interventions
experimental group:Naoxintong Capsule treatment
control group:Conventional treatment
Sponsors
Foshan Sanshui District People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. 18 years old =5.2mmol/L; 3. High triglyceride, TG>=1.7mmol/L; 4. Abnormal low density lipoprotein level, LDL-C>=3.4mmol/L; 5. Abnormal high density lipoprotein level, HDL-C< 1.0mmol /L; Any of the above five conditions can be met.
Exclusion criteria
Exclusion criteria: 1. Cardiac arrest, cardiopulmonary resuscitation, the latter; 2. Patients with serious blood system diseases (hemophilia, severe anemia, thrombocytopenic purpura, essential thrombocythemia); 3. Severe renal insufficiency (serum creatinine level >= 220umol/L); 4. Severe liver disease (cirrhosis or liver cancer), liver function impairment (serum alanine aminotransferase/aspartate aminotransferase > 2 times the upper limit of normal); 5. Allergic to Naoxintong capsule.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic effect; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intestinal flora changes;Lipid metabolism;Hepatic and renal function;Blood routine examination;Routine urine examination;Stool routine examination;Coagulation function; | — |
Countries
China
Contacts
Public ContactLiao XuXing
Foshan Sanshui District People's Hospital
Outcome results
None listed